🇺🇸 FDA
Patent

US 7723340

Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith

granted A61KA61K31/52A61P

Quick answer

US patent 7723340 (Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith) held by Pharmacopeia Drug Discovery, Inc. expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pharmacopeia Drug Discovery, Inc.
Grant date
Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
51
CPC classes
A61K, A61K31/52, A61P, A61P1/00, A61P1/04